Discovery of Alcohol Exposure Biomarkers via Affinity Mass Spectrometry

Information

  • Research Project
  • 7099958
  • ApplicationId
    7099958
  • Core Project Number
    R43AA016223
  • Full Project Number
    1R43AA016223-01
  • Serial Number
    16223
  • FOA Number
    RFA-AA-06-01
  • Sub Project Id
  • Project Start Date
    9/20/2006 - 17 years ago
  • Project End Date
    9/30/2008 - 15 years ago
  • Program Officer Name
    GUO, QINGBIN
  • Budget Start Date
    9/20/2006 - 17 years ago
  • Budget End Date
    9/30/2008 - 15 years ago
  • Fiscal Year
    2006
  • Support Year
    1
  • Suffix
  • Award Notice Date
    9/19/2006 - 17 years ago

Discovery of Alcohol Exposure Biomarkers via Affinity Mass Spectrometry

[unreadable] DESCRIPTION (provided by applicant): The objective of this proposal is to apply novel affinity mass spectrometry (AMS) technologies to identify protein biomarker fingerprints indicative of alcohol consumption. The methodology used combines micro-affinity protein capture from complex biological solutions with mass spectrometric detection. In this first phase (R43), we will screen a small number of plasma samples (n=48) to identify candidate protein profiles, that can appropriately differentiate sample origin from healthy abstinent controls from individuals differentially exposed to alcohol. These samples will be screened with affinity pipettes employing numerous wide specificity affinity surfaces, which include hydrophilic, hydrophobic and metal chelating ligands to name a few. Each of these ligand surfaces possesses specific affinity characteristics that will result in the capture and purification of various protein groups. Observed molecular profiles (fingerprints) that have statistically significant features that correctly group samples will be viewed as potential biomarkers. In the second (validation) phase (R44), we will construct immuno-targeted assays for identified significant features determined within each biomarker fingerprint and individually validate them against a larger number of samples (n=400). In the event that multiple protein biomarkers are validated, a multiplexed immuno-based AMS panel for alcohol exposure will be developed. This will be achieved through the construction of [unreadable] multi-analyte affinity pipettes that will selectively retrieve the targeted biomarkers that differentiate healthy from diseased states. Such panels will also be subject to the same validation process that each of its components individually endured. The ultimate result of this research will be a validated protein biomarker assay(s) that can be used to screen for alcohol exposure. [unreadable] [unreadable] [unreadable]

IC Name
NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM
  • Activity
    R43
  • Administering IC
    AA
  • Application Type
    1
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
    109460
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    273
  • Ed Inst. Type
  • Funding ICs
    NIAAA:109460\
  • Funding Mechanism
  • Study Section
    ZAA1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    INTRINSIC BIOPROBES, INC.
  • Organization Department
  • Organization DUNS
    965127038
  • Organization City
    TEMPE
  • Organization State
    AZ
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    85284
  • Organization District
    UNITED STATES